Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/100893
DC FieldValueLanguage
dc.contributor.authorJarimba, Roberto Saldanha-
dc.contributor.authorEliseu, Miguel Nobre-
dc.contributor.authorPedroso Lima, João-
dc.contributor.authorQuaresma, Vasco-
dc.contributor.authorMoreira, Pedro-
dc.contributor.authorNunes, Pedro Coelho-
dc.contributor.authorSilva, Edgar Tavares da-
dc.contributor.authorFigueiredo, Arnaldo José-
dc.date.accessioned2022-07-19T09:33:59Z-
dc.date.available2022-07-19T09:33:59Z-
dc.date.issued2021-12-20-
dc.identifier.issn2282-4197pt
dc.identifier.issn1124-3562pt
dc.identifier.urihttps://hdl.handle.net/10316/100893-
dc.description.abstractProstate cancer is the most common cancer in men, accounting for 15% of all diagnosed cancers and is the sixth leading cause of cancerrelated deaths amongst men worldwide. Abiraterone and enzalutamide were the first two novel hormonal agents approved for the treatment of metastatic prostate cancer but there is a lack of quality evidence regarding which is associated with better outcomes and who would benefit the most with one or another of these drugs.pt
dc.language.isoengpt
dc.rightsopenAccesspt
dc.subjectProstate cancerpt
dc.subjectAbirateronept
dc.subjectEnzalutamidept
dc.subjectCastration-resistantpt
dc.subject.meshAbiraterone Acetatept
dc.subject.meshHumanspt
dc.subject.meshMalept
dc.subject.meshProspective Studiespt
dc.subject.meshRetrospective Studiespt
dc.subject.meshTreatment Outcomept
dc.subject.meshAntineoplastic Agentspt
dc.subject.meshProstatic Neoplasms, Castration-Resistantpt
dc.titleNovel hormonal agents for metastatic Castration-Resistant Prostate Cancer: comparing outcomes. A single-center retrospective studypt
dc.typearticle-
degois.publication.firstPage393pt
degois.publication.lastPage398pt
degois.publication.issue4pt
degois.publication.titleArchivio Italiano di Urologia e Andrologiapt
dc.peerreviewedyespt
dc.identifier.doi10.4081/aiua.2021.4.393pt
degois.publication.volume93pt
dc.date.embargo2021-12-20*
uc.date.periodoEmbargo0pt
item.grantfulltextopen-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextCom Texto completo-
item.openairetypearticle-
item.cerifentitytypePublications-
item.languageiso639-1en-
Appears in Collections:FMUC Medicina - Artigos em Revistas Internacionais
Files in This Item:
File Description SizeFormat
Novel-hormonal-agents-for-metastatic-CastrationResistant-Prostate-Cancer-Comparing-outcomes-A-singlecenter-retrospective-studyArchivio-Italiano-di-Urologia-e-Andrologia.pdf61.23 MBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

2
checked on Nov 17, 2022

WEB OF SCIENCETM
Citations

1
checked on Nov 15, 2022

Page view(s)

127
checked on Oct 30, 2024

Download(s)

57
checked on Oct 30, 2024

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.